Patents Examined by Sidney J. Friedman
  • Patent number: 5030645
    Abstract: (S)-.alpha.-fluoromethylhistidine, a potent, selective, mechanism-based inhibitor of mammalian histidine carboxylase, the enzyme responsible for biosynthesis of histamine in mammals, is useful in the treatment of asthma.
    Type: Grant
    Filed: October 15, 1990
    Date of Patent: July 9, 1991
    Assignee: Merck & Co., Inc.
    Inventor: Janos Kollonitsch
  • Patent number: 4962121
    Abstract: A method and composition is described for treating neurological diseases such as migraine, by influencing the nerve cells. This is achieved by optimizing the ability of the nerve cell gliacytes to transport taurine and the ability of the nerve cells to absorb taurine, by the external supply of amino acids occurring normally in the body. Preferred compositions include taurine, L-carnitine, zinc gluconate and calcium glycerophosphate.
    Type: Grant
    Filed: April 21, 1988
    Date of Patent: October 9, 1990
    Inventors: Anders Hamberger, Nico M. Van Gelder
  • Patent number: 4324778
    Abstract: The acute liver toxicity effects of paracetamol are reduced by co-formulating with ascorbic acid derivatives (ascorbate anion bioprecursors) which produce high liver concentrations of ascorbate anion after oral administration of the co-formulation. A suitable ascorbate anion bioprecursor is ascorbyl 6-palmitate.
    Type: Grant
    Filed: January 29, 1980
    Date of Patent: April 13, 1982
    Assignee: Beecham Group Limited
    Inventor: Adrian F. Davis